Champions Oncology
CSBR
CSBR
25 hedge funds and large institutions have $33M invested in Champions Oncology in 2026 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
17% less capital invested
Capital invested by funds: $39.7M → $33M (-$6.78M)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $133K
Holders
25
Holding in Top 10
1
Calls
–
Puts
$133K
Top Buyers
| 1 | +$197K | |
| 2 | +$80.3K | |
| 3 | +$34.9K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$8.63K |
| 5 |
BlackRock
New York
|
+$7.17K |
Top Sellers
| 1 | -$145K | |
| 2 | -$90K | |
| 3 | -$70.5K | |
| 4 |
Renaissance Technologies
New York
|
-$59.1K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$55.1K |
